Detalhe da pesquisa
1.
Is cancer an intelligent species?
Cancer Metastasis Rev
; 42(4): 1201-1218, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540301
2.
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors.
Int J Mol Sci
; 25(7)2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612563
3.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278078
4.
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights.
Oncology
; 99(3): 135-143, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130682
5.
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
Oncologist
; 24(5): 612-616, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944184
6.
Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Int J Mol Sci
; 18(6)2017 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629196
7.
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells.
Chin J Cancer Res
; 27(5): 491-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26543336
8.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636208
9.
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer.
Int J Cancer
; 135(8): 1978-82, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599551
10.
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?
Biomedicines
; 12(2)2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397990
11.
Circulating tumor cells in high-risk nonmetastatic colorectal cancer.
Tumour Biol
; 34(5): 2507-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23539436
12.
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer.
Cells
; 12(8)2023 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190081
13.
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer.
Front Oncol
; 13: 1160673, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064137
14.
Abiraterone acetate in castration-resistant prostate cancer.
Anticancer Drugs
; 23(3): 247-54, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22123334
15.
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance.
Methods Mol Biol
; 2535: 93-104, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867225
16.
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity.
Cancer Drug Resist
; 5(1): 245-260, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582538
17.
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study.
Oncotarget
; 13: 686-693, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574217
18.
RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.
Cancers (Basel)
; 14(3)2022 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35159069
19.
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer.
Front Oncol
; 12: 869485, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837106
20.
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.
J Exp Clin Cancer Res
; 41(1): 86, 2022 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260172